nodes	percent_of_prediction	percent_of_DWPC	metapath
Aciclovir—SLC10A2—esophageal cancer	0.877	1	CbGaD
Aciclovir—SLC22A8—Methotrexate—esophageal cancer	0.0123	0.589	CbGbCtD
Aciclovir—SLC22A6—Methotrexate—esophageal cancer	0.00858	0.411	CbGbCtD
Aciclovir—Valaciclovir—SLC10A2—esophageal cancer	0.00493	1	CrCbGaD
Aciclovir—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000959	0.0548	CbGpPWpGaD
Aciclovir—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000877	0.0501	CbGpPWpGaD
Aciclovir—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.000819	0.0468	CbGpPWpGaD
Aciclovir—SLC22A1—Abacavir transmembrane transport—ABCB1—esophageal cancer	0.000745	0.0426	CbGpPWpGaD
Aciclovir—Pain—Carboplatin—esophageal cancer	0.000664	0.00832	CcSEcCtD
Aciclovir—Throat sore—Capecitabine—esophageal cancer	0.000653	0.00818	CcSEcCtD
Aciclovir—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000647	0.0081	CcSEcCtD
Aciclovir—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000618	0.0353	CbGpPWpGaD
Aciclovir—Body temperature increased—Carboplatin—esophageal cancer	0.000614	0.00769	CcSEcCtD
Aciclovir—Skin exfoliation—Cisplatin—esophageal cancer	0.000609	0.00763	CcSEcCtD
Aciclovir—Rhinorrhoea—Capecitabine—esophageal cancer	0.000581	0.00728	CcSEcCtD
Aciclovir—Rigors—Capecitabine—esophageal cancer	0.000576	0.00722	CcSEcCtD
Aciclovir—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000565	0.0323	CbGpPWpGaD
Aciclovir—Encephalopathy—Methotrexate—esophageal cancer	0.000546	0.00684	CcSEcCtD
Aciclovir—Phlebitis—Cisplatin—esophageal cancer	0.000538	0.00674	CcSEcCtD
Aciclovir—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000517	0.00648	CcSEcCtD
Aciclovir—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000517	0.00648	CcSEcCtD
Aciclovir—Herpes simplex—Capecitabine—esophageal cancer	0.000511	0.0064	CcSEcCtD
Aciclovir—Renal failure acute—Cisplatin—esophageal cancer	0.000502	0.00629	CcSEcCtD
Aciclovir—Dysarthria—Capecitabine—esophageal cancer	0.000497	0.00623	CcSEcCtD
Aciclovir—Inflammation—Capecitabine—esophageal cancer	0.000485	0.00608	CcSEcCtD
Aciclovir—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000471	0.00589	CcSEcCtD
Aciclovir—Stupor—Methotrexate—esophageal cancer	0.000469	0.00588	CcSEcCtD
Aciclovir—Depressed level of consciousness—Capecitabine—esophageal cancer	0.000454	0.00569	CcSEcCtD
Aciclovir—Skin exfoliation—Capecitabine—esophageal cancer	0.000449	0.00563	CcSEcCtD
Aciclovir—Face oedema—Cisplatin—esophageal cancer	0.000447	0.0056	CcSEcCtD
Aciclovir—Necrosis—Methotrexate—esophageal cancer	0.000446	0.00559	CcSEcCtD
Aciclovir—Irritability—Cisplatin—esophageal cancer	0.000442	0.00554	CcSEcCtD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000436	0.0249	CbGpPWpGaD
Aciclovir—Blood creatinine increased—Cisplatin—esophageal cancer	0.000434	0.00544	CcSEcCtD
Aciclovir—Dehydration—Cisplatin—esophageal cancer	0.000431	0.0054	CcSEcCtD
Aciclovir—SLC22A1—Abacavir transport and metabolism—ABCB1—esophageal cancer	0.000428	0.0245	CbGpPWpGaD
Aciclovir—Hypokalaemia—Cisplatin—esophageal cancer	0.000422	0.00528	CcSEcCtD
Aciclovir—Cramp muscle—Cisplatin—esophageal cancer	0.000417	0.00523	CcSEcCtD
Aciclovir—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000417	0.00523	CcSEcCtD
Aciclovir—Nasopharyngitis—Cisplatin—esophageal cancer	0.000414	0.00519	CcSEcCtD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000399	0.0228	CbGpPWpGaD
Aciclovir—Phlebitis—Capecitabine—esophageal cancer	0.000396	0.00497	CcSEcCtD
Aciclovir—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000393	0.00492	CcSEcCtD
Aciclovir—Sweating increased—Cisplatin—esophageal cancer	0.00039	0.00489	CcSEcCtD
Aciclovir—Photosensitivity—Capecitabine—esophageal cancer	0.000389	0.00487	CcSEcCtD
Aciclovir—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000385	0.00483	CcSEcCtD
Aciclovir—Abdominal discomfort—Cisplatin—esophageal cancer	0.000384	0.00481	CcSEcCtD
Aciclovir—Herpes simplex—Methotrexate—esophageal cancer	0.00038	0.00476	CcSEcCtD
Aciclovir—Dysarthria—Methotrexate—esophageal cancer	0.00037	0.00464	CcSEcCtD
Aciclovir—Renal failure acute—Capecitabine—esophageal cancer	0.00037	0.00463	CcSEcCtD
Aciclovir—Inflammation—Methotrexate—esophageal cancer	0.000361	0.00452	CcSEcCtD
Aciclovir—Renal impairment—Capecitabine—esophageal cancer	0.000359	0.0045	CcSEcCtD
Aciclovir—Thirst—Capecitabine—esophageal cancer	0.000359	0.0045	CcSEcCtD
Aciclovir—Vasculitis—Methotrexate—esophageal cancer	0.000359	0.0045	CcSEcCtD
Aciclovir—Renal failure—Cisplatin—esophageal cancer	0.000351	0.0044	CcSEcCtD
Aciclovir—Lethargy—Capecitabine—esophageal cancer	0.000349	0.00437	CcSEcCtD
Aciclovir—Conjunctivitis—Cisplatin—esophageal cancer	0.000347	0.00435	CcSEcCtD
Aciclovir—Pain in extremity—Capecitabine—esophageal cancer	0.000342	0.00428	CcSEcCtD
Aciclovir—Osteoarthritis—Capecitabine—esophageal cancer	0.000342	0.00428	CcSEcCtD
Aciclovir—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000338	0.00424	CcSEcCtD
Aciclovir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000338	0.00423	CcSEcCtD
Aciclovir—Skin exfoliation—Methotrexate—esophageal cancer	0.000334	0.00419	CcSEcCtD
Aciclovir—Face oedema—Capecitabine—esophageal cancer	0.00033	0.00413	CcSEcCtD
Aciclovir—Aplastic anaemia—Methotrexate—esophageal cancer	0.000329	0.00412	CcSEcCtD
Aciclovir—Irritability—Capecitabine—esophageal cancer	0.000326	0.00408	CcSEcCtD
Aciclovir—Ataxia—Capecitabine—esophageal cancer	0.000321	0.00402	CcSEcCtD
Aciclovir—Coma—Methotrexate—esophageal cancer	0.00032	0.00401	CcSEcCtD
Aciclovir—Blood creatinine increased—Capecitabine—esophageal cancer	0.00032	0.00401	CcSEcCtD
Aciclovir—Dehydration—Capecitabine—esophageal cancer	0.000318	0.00398	CcSEcCtD
Aciclovir—Urinary tract disorder—Cisplatin—esophageal cancer	0.000317	0.00397	CcSEcCtD
Aciclovir—Liver function test abnormal—Capecitabine—esophageal cancer	0.000315	0.00395	CcSEcCtD
Aciclovir—Urethral disorder—Cisplatin—esophageal cancer	0.000314	0.00394	CcSEcCtD
Aciclovir—Pulmonary oedema—Methotrexate—esophageal cancer	0.000312	0.00391	CcSEcCtD
Aciclovir—Hypokalaemia—Capecitabine—esophageal cancer	0.000311	0.00389	CcSEcCtD
Aciclovir—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000308	0.00385	CcSEcCtD
Aciclovir—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000308	0.00385	CcSEcCtD
Aciclovir—Nasopharyngitis—Capecitabine—esophageal cancer	0.000305	0.00383	CcSEcCtD
Aciclovir—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000301	0.00377	CcSEcCtD
Aciclovir—Eye disorder—Cisplatin—esophageal cancer	0.0003	0.00375	CcSEcCtD
Aciclovir—Lymphadenopathy—Methotrexate—esophageal cancer	0.000298	0.00373	CcSEcCtD
Aciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000291	0.0166	CbGpPWpGaD
Aciclovir—Photosensitivity—Methotrexate—esophageal cancer	0.00029	0.00363	CcSEcCtD
Aciclovir—Immune system disorder—Cisplatin—esophageal cancer	0.00029	0.00363	CcSEcCtD
Aciclovir—Mediastinal disorder—Cisplatin—esophageal cancer	0.000289	0.00362	CcSEcCtD
Aciclovir—Sweating increased—Capecitabine—esophageal cancer	0.000288	0.0036	CcSEcCtD
Aciclovir—Alopecia—Cisplatin—esophageal cancer	0.000283	0.00355	CcSEcCtD
Aciclovir—Abdominal discomfort—Capecitabine—esophageal cancer	0.000283	0.00355	CcSEcCtD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000281	0.0161	CbGpPWpGaD
Aciclovir—Erythema—Cisplatin—esophageal cancer	0.000279	0.0035	CcSEcCtD
Aciclovir—Neutropenia—Capecitabine—esophageal cancer	0.000276	0.00346	CcSEcCtD
Aciclovir—Renal failure acute—Methotrexate—esophageal cancer	0.000275	0.00345	CcSEcCtD
Aciclovir—Flatulence—Cisplatin—esophageal cancer	0.000275	0.00344	CcSEcCtD
Aciclovir—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000274	0.00344	CcSEcCtD
Aciclovir—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000269	0.00338	CcSEcCtD
Aciclovir—Muscle spasms—Cisplatin—esophageal cancer	0.000268	0.00336	CcSEcCtD
Aciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000266	0.0152	CbGpPWpGaD
Aciclovir—Tremor—Cisplatin—esophageal cancer	0.000261	0.00327	CcSEcCtD
Aciclovir—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000261	0.00327	CcSEcCtD
Aciclovir—Lethargy—Methotrexate—esophageal cancer	0.000259	0.00325	CcSEcCtD
Aciclovir—Ill-defined disorder—Cisplatin—esophageal cancer	0.000259	0.00324	CcSEcCtD
Aciclovir—Renal failure—Capecitabine—esophageal cancer	0.000259	0.00324	CcSEcCtD
Aciclovir—Anaemia—Cisplatin—esophageal cancer	0.000258	0.00323	CcSEcCtD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000257	0.0147	CbGpPWpGaD
Aciclovir—Jaundice—Capecitabine—esophageal cancer	0.000257	0.00321	CcSEcCtD
Aciclovir—Conjunctivitis—Capecitabine—esophageal cancer	0.000256	0.0032	CcSEcCtD
Aciclovir—Osteoarthritis—Methotrexate—esophageal cancer	0.000254	0.00319	CcSEcCtD
Aciclovir—Malaise—Cisplatin—esophageal cancer	0.000252	0.00315	CcSEcCtD
Aciclovir—Haematuria—Capecitabine—esophageal cancer	0.000251	0.00314	CcSEcCtD
Aciclovir—Leukopenia—Cisplatin—esophageal cancer	0.00025	0.00313	CcSEcCtD
Aciclovir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000249	0.00312	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000248	0.0142	CbGpPWpGaD
Aciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000243	0.0139	CbGpPWpGaD
Aciclovir—Irritability—Methotrexate—esophageal cancer	0.000243	0.00304	CcSEcCtD
Aciclovir—Convulsion—Cisplatin—esophageal cancer	0.000242	0.00303	CcSEcCtD
Aciclovir—Ataxia—Methotrexate—esophageal cancer	0.000239	0.00299	CcSEcCtD
Aciclovir—Myalgia—Cisplatin—esophageal cancer	0.000238	0.00298	CcSEcCtD
Aciclovir—Hepatitis—Capecitabine—esophageal cancer	0.000236	0.00296	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000236	0.00296	CcSEcCtD
Aciclovir—Liver function test abnormal—Methotrexate—esophageal cancer	0.000235	0.00294	CcSEcCtD
Aciclovir—Discomfort—Cisplatin—esophageal cancer	0.000235	0.00294	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000234	0.0134	CbGpPWpGaD
Aciclovir—Urinary tract disorder—Capecitabine—esophageal cancer	0.000233	0.00292	CcSEcCtD
Aciclovir—Oedema peripheral—Capecitabine—esophageal cancer	0.000233	0.00292	CcSEcCtD
Aciclovir—Urethral disorder—Capecitabine—esophageal cancer	0.000232	0.0029	CcSEcCtD
Aciclovir—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000229	0.00287	CcSEcCtD
Aciclovir—Oedema—Cisplatin—esophageal cancer	0.000228	0.00285	CcSEcCtD
Aciclovir—Anaphylactic shock—Cisplatin—esophageal cancer	0.000228	0.00285	CcSEcCtD
Aciclovir—Erythema multiforme—Capecitabine—esophageal cancer	0.000223	0.0028	CcSEcCtD
Aciclovir—Nervous system disorder—Cisplatin—esophageal cancer	0.000223	0.0028	CcSEcCtD
Aciclovir—Thrombocytopenia—Cisplatin—esophageal cancer	0.000223	0.00279	CcSEcCtD
Aciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000222	0.0127	CbGpPWpGaD
Aciclovir—Tachycardia—Cisplatin—esophageal cancer	0.000222	0.00278	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000221	0.0127	CbGpPWpGaD
Aciclovir—Skin disorder—Cisplatin—esophageal cancer	0.000221	0.00277	CcSEcCtD
Aciclovir—Eye disorder—Capecitabine—esophageal cancer	0.000221	0.00277	CcSEcCtD
Aciclovir—Hyperhidrosis—Cisplatin—esophageal cancer	0.00022	0.00276	CcSEcCtD
Aciclovir—Anorexia—Cisplatin—esophageal cancer	0.000217	0.00272	CcSEcCtD
Aciclovir—Immune system disorder—Capecitabine—esophageal cancer	0.000213	0.00267	CcSEcCtD
Aciclovir—Mediastinal disorder—Capecitabine—esophageal cancer	0.000213	0.00267	CcSEcCtD
Aciclovir—Hypotension—Cisplatin—esophageal cancer	0.000213	0.00267	CcSEcCtD
Aciclovir—Chills—Capecitabine—esophageal cancer	0.000212	0.00266	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000211	0.0121	CbGpPWpGaD
Aciclovir—Abdominal discomfort—Methotrexate—esophageal cancer	0.000211	0.00264	CcSEcCtD
Aciclovir—Alopecia—Capecitabine—esophageal cancer	0.000209	0.00262	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000207	0.0026	CcSEcCtD
Aciclovir—Erythema—Capecitabine—esophageal cancer	0.000206	0.00258	CcSEcCtD
Aciclovir—Neutropenia—Methotrexate—esophageal cancer	0.000205	0.00257	CcSEcCtD
Aciclovir—Paraesthesia—Cisplatin—esophageal cancer	0.000204	0.00256	CcSEcCtD
Aciclovir—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000204	0.00256	CcSEcCtD
Aciclovir—Dyspnoea—Cisplatin—esophageal cancer	0.000203	0.00254	CcSEcCtD
Aciclovir—Flatulence—Capecitabine—esophageal cancer	0.000203	0.00254	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000203	0.0116	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000203	0.0116	CbGpPWpGaD
Aciclovir—Dysgeusia—Capecitabine—esophageal cancer	0.000201	0.00252	CcSEcCtD
Aciclovir—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000201	0.00251	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000199	0.0114	CbGpPWpGaD
Aciclovir—Decreased appetite—Cisplatin—esophageal cancer	0.000198	0.00248	CcSEcCtD
Aciclovir—Muscle spasms—Capecitabine—esophageal cancer	0.000198	0.00248	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000197	0.00246	CcSEcCtD
Aciclovir—Pain—Cisplatin—esophageal cancer	0.000195	0.00244	CcSEcCtD
Aciclovir—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000194	0.00243	CcSEcCtD
Aciclovir—Tremor—Capecitabine—esophageal cancer	0.000193	0.00241	CcSEcCtD
Aciclovir—Renal failure—Methotrexate—esophageal cancer	0.000193	0.00241	CcSEcCtD
Aciclovir—Ill-defined disorder—Capecitabine—esophageal cancer	0.000191	0.00239	CcSEcCtD
Aciclovir—Conjunctivitis—Methotrexate—esophageal cancer	0.00019	0.00239	CcSEcCtD
Aciclovir—Anaemia—Capecitabine—esophageal cancer	0.00019	0.00238	CcSEcCtD
Aciclovir—SLC10A2—Orphan transporters—CREBBP—esophageal cancer	0.00019	0.0108	CbGpPWpGaD
Aciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000189	0.0108	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000188	0.0108	CbGpPWpGaD
Aciclovir—Feeling abnormal—Cisplatin—esophageal cancer	0.000188	0.00235	CcSEcCtD
Aciclovir—Haematuria—Methotrexate—esophageal cancer	0.000187	0.00234	CcSEcCtD
Aciclovir—Malaise—Capecitabine—esophageal cancer	0.000185	0.00232	CcSEcCtD
Aciclovir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000185	0.00232	CcSEcCtD
Aciclovir—Vertigo—Capecitabine—esophageal cancer	0.000185	0.00231	CcSEcCtD
Aciclovir—Leukopenia—Capecitabine—esophageal cancer	0.000184	0.00231	CcSEcCtD
Aciclovir—Palpitations—Capecitabine—esophageal cancer	0.000182	0.00228	CcSEcCtD
Aciclovir—Body temperature increased—Cisplatin—esophageal cancer	0.00018	0.00226	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00018	0.0103	CbGpPWpGaD
Aciclovir—Hypertension—Capecitabine—esophageal cancer	0.000178	0.00222	CcSEcCtD
Aciclovir—Hepatitis—Methotrexate—esophageal cancer	0.000176	0.0022	CcSEcCtD
Aciclovir—Chest pain—Capecitabine—esophageal cancer	0.000175	0.00219	CcSEcCtD
Aciclovir—Myalgia—Capecitabine—esophageal cancer	0.000175	0.00219	CcSEcCtD
Aciclovir—Arthralgia—Capecitabine—esophageal cancer	0.000175	0.00219	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000174	0.00218	CcSEcCtD
Aciclovir—Urinary tract disorder—Methotrexate—esophageal cancer	0.000174	0.00218	CcSEcCtD
Aciclovir—Discomfort—Capecitabine—esophageal cancer	0.000173	0.00217	CcSEcCtD
Aciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000173	0.00987	CbGpPWpGaD
Aciclovir—Urethral disorder—Methotrexate—esophageal cancer	0.000172	0.00216	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000172	0.00985	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000172	0.00985	CbGpPWpGaD
Aciclovir—Confusional state—Capecitabine—esophageal cancer	0.000169	0.00212	CcSEcCtD
Aciclovir—Oedema—Capecitabine—esophageal cancer	0.000168	0.0021	CcSEcCtD
Aciclovir—Hypersensitivity—Cisplatin—esophageal cancer	0.000168	0.0021	CcSEcCtD
Aciclovir—Erythema multiforme—Methotrexate—esophageal cancer	0.000166	0.00208	CcSEcCtD
Aciclovir—Nervous system disorder—Capecitabine—esophageal cancer	0.000165	0.00206	CcSEcCtD
Aciclovir—Eye disorder—Methotrexate—esophageal cancer	0.000164	0.00206	CcSEcCtD
Aciclovir—Thrombocytopenia—Capecitabine—esophageal cancer	0.000164	0.00206	CcSEcCtD
Aciclovir—Tachycardia—Capecitabine—esophageal cancer	0.000164	0.00205	CcSEcCtD
Aciclovir—Asthenia—Cisplatin—esophageal cancer	0.000163	0.00205	CcSEcCtD
Aciclovir—Skin disorder—Capecitabine—esophageal cancer	0.000163	0.00204	CcSEcCtD
Aciclovir—Hyperhidrosis—Capecitabine—esophageal cancer	0.000162	0.00203	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00016	0.00915	CbGpPWpGaD
Aciclovir—Anorexia—Capecitabine—esophageal cancer	0.00016	0.002	CcSEcCtD
Aciclovir—Immune system disorder—Methotrexate—esophageal cancer	0.000159	0.00199	CcSEcCtD
Aciclovir—Mediastinal disorder—Methotrexate—esophageal cancer	0.000159	0.00199	CcSEcCtD
Aciclovir—Chills—Methotrexate—esophageal cancer	0.000158	0.00198	CcSEcCtD
Aciclovir—Hypotension—Capecitabine—esophageal cancer	0.000157	0.00196	CcSEcCtD
Aciclovir—Diarrhoea—Cisplatin—esophageal cancer	0.000156	0.00195	CcSEcCtD
Aciclovir—Alopecia—Methotrexate—esophageal cancer	0.000155	0.00195	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000154	0.00878	CbGpPWpGaD
Aciclovir—Erythema—Methotrexate—esophageal cancer	0.000153	0.00192	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000153	0.00192	CcSEcCtD
Aciclovir—Insomnia—Capecitabine—esophageal cancer	0.000152	0.0019	CcSEcCtD
Aciclovir—Paraesthesia—Capecitabine—esophageal cancer	0.000151	0.00189	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000151	0.00861	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00015	0.00858	CbGpPWpGaD
Aciclovir—Dysgeusia—Methotrexate—esophageal cancer	0.00015	0.00188	CcSEcCtD
Aciclovir—Dyspnoea—Capecitabine—esophageal cancer	0.00015	0.00187	CcSEcCtD
Aciclovir—Dyspepsia—Capecitabine—esophageal cancer	0.000148	0.00185	CcSEcCtD
Aciclovir—Decreased appetite—Capecitabine—esophageal cancer	0.000146	0.00183	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000145	0.00182	CcSEcCtD
Aciclovir—Vomiting—Cisplatin—esophageal cancer	0.000145	0.00181	CcSEcCtD
Aciclovir—Fatigue—Capecitabine—esophageal cancer	0.000145	0.00181	CcSEcCtD
Aciclovir—Rash—Cisplatin—esophageal cancer	0.000144	0.0018	CcSEcCtD
Aciclovir—Constipation—Capecitabine—esophageal cancer	0.000144	0.0018	CcSEcCtD
Aciclovir—Pain—Capecitabine—esophageal cancer	0.000144	0.0018	CcSEcCtD
Aciclovir—Dermatitis—Cisplatin—esophageal cancer	0.000143	0.0018	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000143	0.00816	CbGpPWpGaD
Aciclovir—Ill-defined disorder—Methotrexate—esophageal cancer	0.000142	0.00178	CcSEcCtD
Aciclovir—Anaemia—Methotrexate—esophageal cancer	0.000142	0.00177	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000139	0.00796	CbGpPWpGaD
Aciclovir—Feeling abnormal—Capecitabine—esophageal cancer	0.000138	0.00173	CcSEcCtD
Aciclovir—Malaise—Methotrexate—esophageal cancer	0.000138	0.00173	CcSEcCtD
Aciclovir—Vertigo—Methotrexate—esophageal cancer	0.000138	0.00172	CcSEcCtD
Aciclovir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000137	0.00172	CcSEcCtD
Aciclovir—Leukopenia—Methotrexate—esophageal cancer	0.000137	0.00172	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000136	0.00778	CbGpPWpGaD
Aciclovir—Nausea—Cisplatin—esophageal cancer	0.000135	0.00169	CcSEcCtD
Aciclovir—Urticaria—Capecitabine—esophageal cancer	0.000133	0.00167	CcSEcCtD
Aciclovir—Abdominal pain—Capecitabine—esophageal cancer	0.000133	0.00166	CcSEcCtD
Aciclovir—Body temperature increased—Capecitabine—esophageal cancer	0.000133	0.00166	CcSEcCtD
Aciclovir—Convulsion—Methotrexate—esophageal cancer	0.000133	0.00166	CcSEcCtD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000132	0.00756	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000131	0.00749	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000131	0.00746	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000131	0.00746	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000131	0.00746	CbGpPWpGaD
Aciclovir—Arthralgia—Methotrexate—esophageal cancer	0.00013	0.00163	CcSEcCtD
Aciclovir—Chest pain—Methotrexate—esophageal cancer	0.00013	0.00163	CcSEcCtD
Aciclovir—Myalgia—Methotrexate—esophageal cancer	0.00013	0.00163	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000129	0.00162	CcSEcCtD
Aciclovir—Discomfort—Methotrexate—esophageal cancer	0.000129	0.00161	CcSEcCtD
Aciclovir—Confusional state—Methotrexate—esophageal cancer	0.000126	0.00158	CcSEcCtD
Aciclovir—Anaphylactic shock—Methotrexate—esophageal cancer	0.000125	0.00157	CcSEcCtD
Aciclovir—Hypersensitivity—Capecitabine—esophageal cancer	0.000124	0.00155	CcSEcCtD
Aciclovir—Nervous system disorder—Methotrexate—esophageal cancer	0.000123	0.00154	CcSEcCtD
Aciclovir—Thrombocytopenia—Methotrexate—esophageal cancer	0.000122	0.00153	CcSEcCtD
Aciclovir—Skin disorder—Methotrexate—esophageal cancer	0.000121	0.00152	CcSEcCtD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000121	0.00692	CbGpPWpGaD
Aciclovir—Hyperhidrosis—Methotrexate—esophageal cancer	0.000121	0.00151	CcSEcCtD
Aciclovir—Asthenia—Capecitabine—esophageal cancer	0.00012	0.00151	CcSEcCtD
Aciclovir—Anorexia—Methotrexate—esophageal cancer	0.000119	0.00149	CcSEcCtD
Aciclovir—Pruritus—Capecitabine—esophageal cancer	0.000119	0.00149	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000118	0.00677	CbGpPWpGaD
Aciclovir—Hypotension—Methotrexate—esophageal cancer	0.000117	0.00146	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—BLVRB—esophageal cancer	0.000116	0.00665	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SLC52A3—esophageal cancer	0.000116	0.00665	CbGpPWpGaD
Aciclovir—Diarrhoea—Capecitabine—esophageal cancer	0.000115	0.00144	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000114	0.00143	CcSEcCtD
Aciclovir—Insomnia—Methotrexate—esophageal cancer	0.000113	0.00142	CcSEcCtD
Aciclovir—Paraesthesia—Methotrexate—esophageal cancer	0.000112	0.00141	CcSEcCtD
Aciclovir—Dyspnoea—Methotrexate—esophageal cancer	0.000111	0.0014	CcSEcCtD
Aciclovir—Somnolence—Methotrexate—esophageal cancer	0.000111	0.00139	CcSEcCtD
Aciclovir—Dizziness—Capecitabine—esophageal cancer	0.000111	0.00139	CcSEcCtD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00011	0.00631	CbGpPWpGaD
Aciclovir—Dyspepsia—Methotrexate—esophageal cancer	0.00011	0.00138	CcSEcCtD
Aciclovir—Decreased appetite—Methotrexate—esophageal cancer	0.000109	0.00136	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000108	0.00135	CcSEcCtD
Aciclovir—Fatigue—Methotrexate—esophageal cancer	0.000108	0.00135	CcSEcCtD
Aciclovir—Pain—Methotrexate—esophageal cancer	0.000107	0.00134	CcSEcCtD
Aciclovir—Vomiting—Capecitabine—esophageal cancer	0.000107	0.00134	CcSEcCtD
Aciclovir—Rash—Capecitabine—esophageal cancer	0.000106	0.00133	CcSEcCtD
Aciclovir—Dermatitis—Capecitabine—esophageal cancer	0.000106	0.00132	CcSEcCtD
Aciclovir—Headache—Capecitabine—esophageal cancer	0.000105	0.00132	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000104	0.00595	CbGpPWpGaD
Aciclovir—Feeling abnormal—Methotrexate—esophageal cancer	0.000103	0.00129	CcSEcCtD
Aciclovir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000102	0.00128	CcSEcCtD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000101	0.00577	CbGpPWpGaD
Aciclovir—Nausea—Capecitabine—esophageal cancer	9.97e-05	0.00125	CcSEcCtD
Aciclovir—Urticaria—Methotrexate—esophageal cancer	9.93e-05	0.00124	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CA1—esophageal cancer	9.9e-05	0.00566	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.89e-05	0.00565	CbGpPWpGaD
Aciclovir—Body temperature increased—Methotrexate—esophageal cancer	9.88e-05	0.00124	CcSEcCtD
Aciclovir—Abdominal pain—Methotrexate—esophageal cancer	9.88e-05	0.00124	CcSEcCtD
Aciclovir—Hypersensitivity—Methotrexate—esophageal cancer	9.21e-05	0.00115	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CA2—esophageal cancer	9.05e-05	0.00517	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.98e-05	0.00513	CbGpPWpGaD
Aciclovir—Asthenia—Methotrexate—esophageal cancer	8.97e-05	0.00112	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.85e-05	0.00506	CbGpPWpGaD
Aciclovir—Pruritus—Methotrexate—esophageal cancer	8.84e-05	0.00111	CcSEcCtD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	8.58e-05	0.00491	CbGpPWpGaD
Aciclovir—Diarrhoea—Methotrexate—esophageal cancer	8.55e-05	0.00107	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.49e-05	0.00485	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ADH7—esophageal cancer	8.41e-05	0.00481	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PLCE1—esophageal cancer	8.41e-05	0.00481	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.32e-05	0.00475	CbGpPWpGaD
Aciclovir—Dizziness—Methotrexate—esophageal cancer	8.26e-05	0.00104	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.15e-05	0.00466	CbGpPWpGaD
Aciclovir—Vomiting—Methotrexate—esophageal cancer	7.95e-05	0.000995	CcSEcCtD
Aciclovir—Rash—Methotrexate—esophageal cancer	7.88e-05	0.000987	CcSEcCtD
Aciclovir—Dermatitis—Methotrexate—esophageal cancer	7.87e-05	0.000986	CcSEcCtD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	7.85e-05	0.00449	CbGpPWpGaD
Aciclovir—Headache—Methotrexate—esophageal cancer	7.83e-05	0.000981	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	7.54e-05	0.00431	CbGpPWpGaD
Aciclovir—Nausea—Methotrexate—esophageal cancer	7.42e-05	0.00093	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—ADH1B—esophageal cancer	7.38e-05	0.00422	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.22e-05	0.00413	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.09e-05	0.00405	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—TYMP—esophageal cancer	7.05e-05	0.00403	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.93e-05	0.00396	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP26A1—esophageal cancer	6.86e-05	0.00392	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	6.72e-05	0.00384	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ALOX15—esophageal cancer	6.68e-05	0.00382	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—GNG7—esophageal cancer	6.66e-05	0.00381	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.42e-05	0.00367	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTO1—esophageal cancer	6.38e-05	0.00365	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—TPI1—esophageal cancer	6.38e-05	0.00365	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	6.3e-05	0.0036	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	6.24e-05	0.00357	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.15e-05	0.00352	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.15e-05	0.00352	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ALDOB—esophageal cancer	6.11e-05	0.00349	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	5.92e-05	0.00338	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GAPDH—esophageal cancer	5.89e-05	0.00336	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CRABP1—esophageal cancer	5.83e-05	0.00333	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	5.61e-05	0.00321	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GNG7—esophageal cancer	5.55e-05	0.00317	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.47e-05	0.00313	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.44e-05	0.00311	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	5.35e-05	0.00306	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.25e-05	0.003	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ALDH2—esophageal cancer	5.2e-05	0.00297	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	5.13e-05	0.00293	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	5.13e-05	0.00293	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—GNG7—esophageal cancer	5.1e-05	0.00292	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTT1—esophageal cancer	4.94e-05	0.00283	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	4.89e-05	0.0028	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP2A6—esophageal cancer	4.89e-05	0.00279	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.87e-05	0.00278	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—ALDH2—esophageal cancer	4.78e-05	0.00273	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.66e-05	0.00266	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PTGS1—esophageal cancer	4.63e-05	0.00265	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ENO1—esophageal cancer	4.63e-05	0.00265	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.63e-05	0.00265	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	4.6e-05	0.00263	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PSME1—esophageal cancer	4.57e-05	0.00261	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PSME2—esophageal cancer	4.57e-05	0.00261	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	4.36e-05	0.00249	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.23e-05	0.00242	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	4.16e-05	0.00238	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	3.99e-05	0.00228	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	3.99e-05	0.00228	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.99e-05	0.00228	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP1B1—esophageal cancer	3.94e-05	0.00225	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.89e-05	0.00222	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP19A1—esophageal cancer	3.7e-05	0.00212	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	3.53e-05	0.00202	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.51e-05	0.00201	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HMOX1—esophageal cancer	3.38e-05	0.00193	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.32e-05	0.0019	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ABCB1—esophageal cancer	3.24e-05	0.00185	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.02e-05	0.00173	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.74e-05	0.00157	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SLC52A3—esophageal cancer	2.7e-05	0.00154	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—BLVRB—esophageal cancer	2.7e-05	0.00154	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.58e-05	0.00147	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.47e-05	0.00141	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.45e-05	0.0014	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CA1—esophageal cancer	2.29e-05	0.00131	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SLC10A2—esophageal cancer	2.29e-05	0.00131	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CREBBP—esophageal cancer	2.17e-05	0.00124	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.15e-05	0.00123	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CA2—esophageal cancer	2.1e-05	0.0012	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.06e-05	0.00118	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ADH7—esophageal cancer	1.95e-05	0.00111	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PLCE1—esophageal cancer	1.95e-05	0.00111	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NOS3—esophageal cancer	1.94e-05	0.00111	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PTGS2—esophageal cancer	1.78e-05	0.00101	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ADH1B—esophageal cancer	1.71e-05	0.000977	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.67e-05	0.000955	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.65e-05	0.000945	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TYMP—esophageal cancer	1.63e-05	0.000933	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.6e-05	0.000917	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP26A1—esophageal cancer	1.59e-05	0.000908	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ALOX15—esophageal cancer	1.55e-05	0.000885	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTO1—esophageal cancer	1.48e-05	0.000844	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TPI1—esophageal cancer	1.48e-05	0.000844	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—EP300—esophageal cancer	1.48e-05	0.000844	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ALDOB—esophageal cancer	1.42e-05	0.000809	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.38e-05	0.000789	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GAPDH—esophageal cancer	1.36e-05	0.000779	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CRABP1—esophageal cancer	1.35e-05	0.000772	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GNG7—esophageal cancer	1.28e-05	0.000734	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ALDH2—esophageal cancer	1.2e-05	0.000688	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTT1—esophageal cancer	1.15e-05	0.000655	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP2A6—esophageal cancer	1.13e-05	0.000647	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CA—esophageal cancer	1.09e-05	0.000624	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PTGS1—esophageal cancer	1.07e-05	0.000613	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ENO1—esophageal cancer	1.07e-05	0.000613	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.07e-05	0.000613	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PSME1—esophageal cancer	1.06e-05	0.000604	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PSME2—esophageal cancer	1.06e-05	0.000604	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP1B1—esophageal cancer	9.12e-06	0.000521	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP19A1—esophageal cancer	8.58e-06	0.00049	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HMOX1—esophageal cancer	7.83e-06	0.000447	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ABCB1—esophageal cancer	7.51e-06	0.000429	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CREBBP—esophageal cancer	5.02e-06	0.000287	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NOS3—esophageal cancer	4.5e-06	0.000257	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PTGS2—esophageal cancer	4.11e-06	0.000235	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—EP300—esophageal cancer	3.42e-06	0.000195	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CA—esophageal cancer	2.53e-06	0.000145	CbGpPWpGaD
